COMP <GO>
IOSP vs FCX // EV/EBITDA & P/E VALUATION
Innospec Inc. (NASDAQ) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: IOSP 5
— FCX 6
▲ EV/EBITDA & P/E VALUATION LEADER: FCX
LAST: $99.89 (-1.50%) • MKT CAP: $2.50B
valuation
17.0x
LAST: $62.47 (-5.55%) • MKT CAP: $94.98B
valuation
13.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IOSP VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IOSP | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 27.70% | 26.10% | +1.60 | IOSP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 21.50% | -11.60 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.0x | 13.4x | +3.60 | FCX | /valuation <GO> |
| Free Cash Flow Yield | 5.54% | 4.71% | +0.83 | IOSP | /fcf-yield <GO> |
| Operating Margin | 7.30% | 25.90% | -18.60 | FCX | /operating-margins <GO> |
| Net Profit Margin | — | 8.80% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -3.70% | 0.10% | -3.80 | FCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.70% | 0.91% | +0.79 | IOSP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.47 | 3.08 | +2.39 | IOSP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | FCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.6 | 43.5 | +21.10 | IOSP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 40.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.50B | $94.98B | -$92.48B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IOSP REV | FCX REV | IOSP GROSS % | FCX GROSS % | IOSP FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.78B | $25.19B | 27.7% | 26.1% | $138.3M | $4.48B |
| FY 2024 | $1.85B | $25.17B | 29.4% | 29.3% | $184.5M | $6.03B |
| FY 2023 | $1.95B | $22.70B | — | — | $207.3M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IOSP // BETA —
FCX // BETA 0.95